Decreasing Alkaline Phosphatase (ALP) While on Azathioprine

Understanding ALP in the Context of Azathioprine Therapy

• ALP is an enzyme primarily found in the liver, bone, and bile ducts, with elevated levels often indicating hepatobiliary disease or increased bone turnover 1
• When monitoring patients on azathioprine, ALP is one of several liver function tests routinely measured to assess hepatotoxicity 2

Monitoring Guidelines for Patients on Azathioprine

• Patients on azathioprine should have baseline and weekly monitoring of liver tests (including ALP) for the first 4 weeks, then 1-3 monthly thereafter 4
• The British Association of Dermatologists recommends regular monitoring of liver function tests to detect any abnormalities early 6
• Any abnormal liver tests should prompt careful evaluation and increased frequency of repeat testing 2

Clinical Implications of Decreasing ALP

• Decreasing ALP may indicate successful treatment of the underlying condition for which azathioprine was prescribed 3
• In autoimmune hepatitis, normalization of liver tests including ALP is an important endpoint of initial treatment 4
• For inflammatory bowel disease patients, decreasing ALP suggests improvement in any associated liver inflammation 3

Important Considerations for Ongoing Monitoring

• While decreasing ALP is generally positive, it's essential to continue monitoring other parameters, including complete blood count to detect bone marrow suppression 7
• Other liver function tests, including transaminases and bilirubin, should also be monitored 2
• Clinical symptoms of potential azathioprine toxicity should be closely watched 6